EN
HI
Summary
As of 13 Sep, 2026, Medicamen Biotech stock price is ₹323.05. During the trading session, the stock has moved between an intraday low of ₹289.45 and an intraday high of ₹330.00. Over the last 52 weeks, Medicamen Biotech has traded between ₹212.40 and ₹447.65.
The stock has recorded a trading volume of 1,91,712 shares,. Its Average Traded Price (ATP) is ₹315.21, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹323.05.
Medicamen Biotech has an upper circuit limit of ₹387.65 and a lower circuit limit of ₹258.45. The total value traded stands at ₹6.04 CR, and the delivery percentage for the day is 40.06%.
The stock is currently traded with a market lot size of 1. Medicamen Biotech also offers a dividend yield of 0.31%.
Medicamen Biotech Share Price Chart
Medicamen Biotech Share Key Metrics
Volume
1.92 L
Market Cap
438.15 CR
LTQ@LTP
2@323.05
ATP
315.21
Var Margin
23.74 %
Circuit Range
258.45-387.65
Delivery %
40.06 %
Value
6.04 CR
ASM/GSM
No
Market Lot
1
Medicamen Biotech Fundamentals
P/E Ratio
40.52
P/B Ratio
1.62
Div. Yield
0.31
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Medicamen Biotech Resistance and Support
Pivot 311.9
Resistance
First Resistance
322.45
Second Resistance
337.4
Third Resistance
347.95
Support
First Support
296.95
Second Support
286.4
Third Support
271.45
Medicamen Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 301 | 323.05 | 5.06% | 330 | 289.45 |
| Thu Sep 10 2026 | 317.35 | 307.5 | -1.72% | 326.85 | 301.35 |
| Wed Sep 09 2026 | 287.64 | 312.89 | 9.50% | 317.35 | 280.04 |
Medicamen Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-27 | Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-26 | Preferential issue of shares |
| 2025-02-11 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Medicamen Biotech News
Medicamen Biotech Ltd-$ - 531146 - Intimation Of Book Clsoure And Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligationa And Disclosure Requirements) Regulation 2015
Medicamen Biotech has set September 19, 2026, as the Record Date for its final dividend for the financial year ended March 31, 2026. This determines eligible shareholders for the dividend, pending approval at the 33rd AGM.
Aug 18 2026 13:26:05
Medicamen Biotech Management
| Name | Position |
|---|---|
| Rahul Bishnoi | Chairman |
| Vimal Kumar Shrawat | Non Independent & Non Executive Director |
Medicamen Biotech FAQs
The Buying Price of Medicamen Biotech share is 323.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 40.52. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Medicamen Biotech shares is 1.62. Useful to assess the stock's value relative to its book value.
To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Medicamen Biotech is 438.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Medicamen Biotech share price is 447.65 & 212.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Medicamen Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MEDICAMEQ
